IL-12 dependent/IFNγ independent expression of CCR5 by myelin-reactive T cells correlates with encephalitogenicity

LV Bagaeva, LP Williams, BM Segal - Journal of neuroimmunology, 2003 - Elsevier
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating
disease with similarities to multiple sclerosis (MS). It is induced in mice by the transfer of …

Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes

SC Chen, MW Leach, Y Chen, XY Cai… - The Journal of …, 2002 - journals.aai.org
To study the biological role of the chemokine ligands CCL19 and CCL21, we generated
transgenic mice expressing either gene in oligodendrocytes of the CNS. While all transgenic …

Serum levels of CXCL13 are elevated in active multiple sclerosis

ED Festa, K Hankiewicz, S Kim… - Multiple Sclerosis …, 2009 - journals.sagepub.com
There is increasing recognition of the important role that B cells play in the pathogenesis of
multiple sclerosis (MS). Recently it was reported that the B cell chemokine CXCL13 is …

CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function

EA Forde, RNE Dogan, WJ Karpus - Journal of neuroimmunology, 2011 - Elsevier
Chemokines and their receptors play a critical role in orchestrating the immune response
during experimental autoimmune encephalomyelitis (EAE). Expression of CCR4 and its …

Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10

K Boztug, MJ Carson, N Pham-Mitchell… - The Journal of …, 2002 - journals.aai.org
The CXC chemokine ligand (CXCL) 10 is induced locally in the CNS in diverse pathologic
states. The impact of CXCL10 production in the CNS was examined in transgenic mice with …

ACT‐1004‐1239, a first‐in‐class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases

L Pouzol, N Baumlin, A Sassi, M Tunis… - The FASEB …, 2021 - Wiley Online Library
Current strategies for the treatment of demyelinating diseases such as multiple sclerosis
(MS) are based on anti‐inflammatory or immunomodulatory drugs. Those drugs have the …

CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination

JR Patel, EE McCandless… - Proceedings of the …, 2010 - National Acad Sciences
Multiple sclerosis is a neurodegenerative disease characterized by episodes of autoimmune
attack of oligodendrocytes leading to demyelination and progressive functional deficits …

CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement

LMP le Blanc, AWT van Lieshout, GJ Adema… - Neuroscience …, 2006 - Elsevier
In neuro-inflammatory diseases, activated T cells are thought to drive the inflammatory
process. In this study, we investigated the potential role of three T cell attracting chemokines …

Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF …

RNE Dogan, A Elhofy, WJ Karpus - The Journal of Immunology, 2008 - journals.aai.org
Experimental autoimmune encephalomyelitis is a T cell-mediated demyelinating disease of
the CNS that serves as a model for the human disease multiple sclerosis. Increased …

Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment

JJ Grist, BS Marro, DD Skinner… - European journal of …, 2018 - Wiley Online Library
Increasing evidence points to an important role for neutrophils in participating in the
pathogenesis of the human demyelinating disease MS and the animal model EAE …